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“What makes it difficult is that research is 
immersion in the unknown. We just don’t 
know what we’re doing. We can’t be sure 
whether we’re asking the right question or 
doing the right experiment until we get the 
answer or the result.” 
Martin A. Schwartz, “The importance of 
stupidity in scientific research”. Journal of 
Cell Science (2008) 121, 1771 
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Resumo 
 
A quimiocina fractalquina (Fkn) é uma molécula única, expressa constitutivamente por 
neurónios no sistema nervoso central (SNC), enquanto que neste tecido o seu receptor se 
encontra apenas em microglia. Um conjunto crescente de indícios sugere que a Fkn pode 
servir como modulador da interacção entre neurónios e microglia no SNC saudável e/ou 
em casos patológicos. Neste trabalho, investigámos os efeitos moduladores da Fkn no perfil 
inflamatório promovido pelo lipopolissacarídeo (LPS) na linha celular de microglia N9. Os 
nossos resultados mostram que a Fkn induz uma redução na expressão de mRNA para a 
interleucina 1-beta (IL-1β) e para o factor de necrose tumoral-alfa (TNF-α), aumentados 
pelo LPS; aumenta a actividade fagocítica e migratória das células N9 e induz uma 
reorganização do citoesqueleto, quer em condições basais quer na presença de LPS. Em 
suma, a Fkn modula a activação da microglia induzida por LPS, reduzindo o perfil 
inflamatório destas células, mas mantendo elevados níveis de actividade quer fagocítica, 
quer migratória. Os nossos dados confirmam que a Fkn pode ter um papel importante a 
desempenhar em patologias do SNC que sejam afectadas pela desregulação da actividade 
da microglia. O sistema da Fkn surge assim como um alvo importante no tratamento 
destas patologias. 
 
Palavras-chave: fractalquina, microglia, lipopolissacarídeo, migração, fagocitose. 
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Abstract 
 
Fractalkine (Fkn) is a unique chemokine, which is constitutively expressed by neurons in 
the central nervous system (CNS), while in this tissue its receptor is localized only in 
microglia. Increasing evidence suggests that Fkn may act as a key modulator of the cross-
talk between neurons and microglia in health and in disease. In this work, we investigated 
the modulatory effects of Fkn on the inflammatory profile elicited by lipopolysaccharide 
(LPS) in the N9 microglial cell line. Our results show that Fkn reduces interleukin-1 beta 
(IL-1β) and tumour necrosis factor alpha (TNF-α) mRNA expression driven by LPS, 
increases the phagocytic and migratory activity of N9 cells and induces cytoskeleton 
reorganization both in basal conditions and under stimulation with LPS. In summary, Fkn 
modulates LPS-mediated microglial activation, reducing the inflammatory profile while 
maintaining high levels of migratory and phagocytic activity. Our data confirms that Fkn 
may play a major role in CNS pathologies affected by deregulation of microglial activity. 
Thus, Fkn system emerges as an important target for the treatment of such pathologies. 
 
Keywords: fractalkine, microglia, lipopolysaccharide, migration, phagocytosis. 
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Chapter I – Introduction 
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1.1. On the origins of microglia 
 
The publication of del Río-Hortega’s seminal work in 1919 on the physiology and nature of 
what had been described until then as the ‘third element of the nervous system’ marked the 
beginning of a research interest on microglial cells, which has persisted until today 
(reviewed in (Rezaie & Male 2002)). What he observed and described in the early 20th 
century clearly defined the morphology and function of microglia, and the majority of his 
findings remain perfectly valid almost one century later. Broadly, microglial cells are 
critical in the protection of the central nervous system (CNS) against infection, trauma, 
and neurodegenerative processes. Indeed they are considered the resident macrophages of 
the CNS, the primary immune effector cells of the brain (see (Kettenmann et al. 2011) for a 
comprehensive review). Importantly, beyond these “classical” defence-oriented functions 
(e.g. starting inflammatory responses and clearing debris) they have also been linked to 
other, less canonical roles. Microglia have been associated with the development of the 
vascular and neuronal networks, axonal growth, synaptogenesis, neurogenesis, gliogenesis 
and developmental neuronal cell death (reviewed in (Pont-Lezica et al. 2011)). Such are the 
functions not of a strictly immune effector cell type, but of an all-purpose key player in the 
CNS environment (Barres 2008). This puts microglia in a privileged position, both within 
the immune as well as the nervous system, and the fact that these cells express molecules 
such as neuromodulators or receptors for neurotransmitters, and that neurons express 
chemokines and chemokine receptors, hints at a tight crosstalk between these systems 
(Rostène et al. 2011). 
In their 2008 paper, Davoust et al. nicely review the heterogeneous population of CNS-
associated macrophages, as well as their origins (Davoust et al. 2008). Adult microglia are 
thought to derive from two distinct waves of progenitors that invade the CNS. First, during 
embryonic and foetal development, microglia are derived from pial macrophages from the 
mesenchymal progenitor cells at the yolk sac (Alliot et al. 1999; Chan et al. 2007; Davoust 
et al. 2008). Later, before birth (in humans) or in the early postnatal period (in rodents), 
microglial cells originate from circulating monocytes that infiltrate the brain parenchyma 
through the blood-brain barrier (BBB) (Kaur et al. 2001; Davoust et al. 2008). To 
complicate matters further, there is a great difficulty to clearly discriminate parenchymal 
microglia from other macrophage-like cells residing in the CNS (Guillemin & Brew 2004). 
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These are essentially perivascular macrophages, meningeal macrophages and choroid 
plexus macrophages (Davoust et al. 2008). Finally, the replacement of microglia by 
circulating precursors in the adult CNS does not normally occur. This is probably due to 
the inability of myelomonocitic precursors with the capacity to generate microglia to reach 
the circulation (which happens in the case of irradiation/transplant) and the 
unpermissiveness of the BBB after the second wave of postnatal microglial production 
(Ajami et al. 2007). Thus, the resident microglia seem to exhibit enough proliferation 
potential to provide progeny, both with and without pathologies, for the lifetime of the 
organisms (Ajami et al. 2007). 
 
1.2. General characteristics of microglia 
 
1.2.1. In vivo  
 
The morphology of microglial cells has been classically associated with their functional 
state. In vivo, microglia generally display a branched shape with a small soma and fine and 
long processes, very well depicted by del Río-Hortega in 1919 (Fig. 1.1.). This description 
defines the typical morphology of the so-called “resting” microglia, a widespread term for 
non-reactive microglial cells (Kettenmann et al. 2011). Microglial cells can be identified 
and their morphology revealed by a variety of cell surface-associated or cytosolic 
molecules. However, most of these molecules also have established functions and are 
present in macrophages (Kettenmann et al. 2011). While this might be a useful method to 
distinguish microglia from other brain cells (e.g. neurons or macroglia), a clear distinction 
between microglia and infiltrating monocytes/macrophages is difficult due to the overlap in 
the expression of the factors used in microglial staining (reviewed in (Guillemin & Brew 
2004)). This typically happens with receptors or adhesion molecules. For example, the 
integrin alpha M (MAC-1, αMβ2 integrin or CD11b), which serves as complement 3b 
receptor, is involved in the clearance of opsonised material by phagocytosis, and is 
expressed both by macrophages invading the CNS as well as microglia (Guillemin & Brew 
2004). Another widespread marker used to identify microglia morphology is ionized 
calcium (Ca2+) binding adaptor molecule 1 (Iba-1). Iba-1 has been involved in the 
formation of membrane ‘ruffles’ on these cells, suggesting a major role in phagocytosis and 
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migration for this marker (Ohsawa et al. 2000). Other factors that are shared between 
microglia and macrophages are, for example, Fc (fragmented; crystallized)-gamma 
receptors (FcγR) (Peress et al. 1993), major histocompatibility complex (MHC) class II 
molecules (Bo et al. 1994), protein tyrosine phosphatase receptor type C (also leukocyte 
common antigen, LCA, PTPRC, CD45) (Lowe et al. 1989) and F4/80 (Perry et al. 1985).  
 
Figure 1.1. The different morphological states of human microglia in the normal state as illustrated by 
del Río-Hortega in 1919 (adapted from (Rezaie & Male 2002)). (A) Bipolar cell, (B) large cell with two 
nuclei, (C) multipolar cell with ramified expansions, (D) multipolar cell with spinal (thorny) appendages, (E) 
isogenic pair, (F) bipolar corpuscle with bifurcating appendices. 
 
Microglia actively scour the brain parenchyma in the search for tissue debris, damaged 
cells, microbes, or other signals of homeostatic changes, remaining highly dynamic while 
apparently “resting” (Nimmerjahn et al. 2005). This behaviour ensures that signs of 
potential danger to the CNS can evoke rapid responses from this specialized line of 
defence. When presented with challenges or altered homeostasis, profound changes are 
elicited in the microglial cell shape, gene expression and functional behaviour. This 
process, commonly defined as “microglial activation”, should be viewed as a shift from one 
functional phenotype to another rather than an “awakening” (Hanisch & Kettenmann 
2007; Graeber & Streit 2010). Surprisingly, these adjustments can occur in minutes. 
Following activation, ‘resting’ microglia undergo a dramatic restructure of their 
cytoskeleton (Stence et al. 2001). This occurs through a multistep transformation involving 
the replacement of the ramified branches with an entirely new set of highly motile 
protrusions (Fig 1.2.). 
Time-lapse imaging revealed that 30 min post-sacrifice, cells were already in the process of 
retracting branches (‘withdrawal’ or ‘W-stage’), a process which lasts anywhere between a 
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few minutes to several hours, at an average retraction speed of 0.5–1.5 μm/min. Following 
this stage, microglial cells transition into a dynamic ‘motility stage’ (M-stage), which 
involves cycles of extension and retraction of new processes. Some cells begin shaping new 
protrusions only after a significant time delay (30 min or more) following W-stage, 
however, for other cells this occurred already during the final phase of the withdrawal 
process. These cells exhibited a ‘transitional stage’ (T-stage), in which retraction and 
emergence of cytoplasmic processes take place at the same time. 
 
Figure 1.2. Multistep model of microglial activation dynamics. (Stence et al. 2001) 
 
New processes were much more dynamic than the old ones: growth and retraction rate was 
three- to fourfold faster than the rate of retraction of the pre-existing branches. Cells then 
begin to move through the tissue, entering the last, so-called ‘locomotory stage’ (L-stage). 
Moving cells typically had a polarized morphology with one prominent leading process, 
and moved through the tissue at up to 118 μm/h. While moving, cells extended short, 
fleeting processes tangential to the primary direction of movement, which enabled direct 
physical contact with neighbour cells, establishing a support for tissue surveillance function 
(Stence et al. 2001). 
Frequently, the expression levels of some of the aforementioned characteristic 
microglial/macrophage molecules are affected by the activation state of the cells, with an 
induced activation resulting in increased expression levels of CD11b, Iba-1 or MHC class II 
molecules, for example (Kreutzberg 1996; Ito et al. 2001; O'Keefe et al. 2002). Indeed, 
activated microglia express and release a variety of factors in order to control and minimize 
the impact of CNS injuries. Some of them are anti-inflammatory or neurotrophic, released 
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to promote cell survival and tissue recovery after injury. Others are inherently pro-
inflammatory, ensuring restriction in the spread of the injury and rapid elimination of any 
possible insulting agent, but may possibly induce damage to the CNS by themselves (Czeh 
et al. 2011). Amongst the factors released by activated microglia are interleukin-1 beta (IL-
1β), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), monocyte chemotactic 
protein-1 (MCP-1), neuronal growth factor (NGF) and brain-derived neurotrophic factor 
(BDNF), only to mention a few (Fig. 1.3.) (Garden & Möller 2006). These can further act 
upon microglial cells themselves, in autocrine or paracrine loops. The answer to whether 
the outcome of such feedback mechanisms is bad or good may lie in the balance between 
them (Pocock & Liddle 2001). 
 
Figure 1.3. Receptors and effector molecules expressed by microglia. (Lucin & Wyss-Coray 2009). 
 
1.2.2. In vitro  
 
It is important to note that microglial cells cultured in vitro do not display the highly 
ramified structure that is typically observed in the normal, healthy CNS. Instead, they show 
heterogeneous shapes. Cells adopt a much less ramified, bipolar morphology, or amoeboid 
versions with short thick processes expanding as lamellipodia, depending on culture times 
and states of activation (Suzumura et al. 1991). Commonly, untreated cultured microglial 
cells exhibit a rounded, amoeboid morphology, and seem to be at least partially activated 
(Eder et al. 1999). Also, ex vivo microglial cells analysed immediately upon isolation 
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resemble the reactive amoeboid microglia normally found in inflamed or wounded CNS 
(Becher & Antel 1996). This activation seems to wane with time and passage of the cells, 
with an approximation to the typical "resting" in vivo morphology (Lauro et al. 1995), and 
it has also been reduced through the use of retinoic acid (Giulian & Baker 1986).  
 
1.2.2.1. Organotypical cultures 
 
Organotypic hippocampal slice cultures (OHSCs) are known to preserve physiological and 
morphological conditions of the in vivo situation regarding neuronal and some non-
neuronal cells (Noraberg et al. 2005). However, explantation and in vitro cultivation of 
hippocampal slices were accompanied by a massive microglial reaction, taking place on 
slice surfaces and, to a lesser extent, inside the intermediate layers (Fig. 1.4.) (Hailer et al. 
1996). This activation correlated with the distribution of dead or injured neuronal cells, 
either spontaneous or induced (Heppner et al. 1998). Since loss of neurons in OHSCs 
predominantly occurs right after explantation, significantly lower rate of spontaneous 
neuronal degeneration is reached after a few days in vitro, which enables microglial cells to 
gradually return to a ‘resting’ state (Hailer et al. 1996). Microglia in slice cultures respond 
to stimulation and retain their functional capabilities for producing superoxide anions or 
to engage in phagocytic activities (Czapiga & Colton 1999), and as such this model system 
can be useful to examine the interactions of microglia with neurons and other glia in the 
normal and injured brain. Of course, this comes at a high cost in both biological material as 
well as time, and alternative models to study microglial form and function have been 
optimized. 
 
1.2.2.2. Primary cultures 
 
Primary microglia cultures are most often derived from the cortex of a rat or mouse before 
or early after birth, generally through a protocol described by Giulian and Baker (Giulian & 
Baker 1986). The advantages of using amoeboid microglia directly from an animal are 
related to the functional characteristics that these cells are endowed with, such as secretory 
products, cell surface markers and phagocytic activity, which closely resemble those of cells 
in endogenous environment (Lauro et al. 1995). Indeed, morphological reorganization of 
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this isolated microglia can still be imposed by treatment with typical activating agents, such 
as bacterial lipopolysaccharide (LPS) (Abd-El-Basset & Fedoroff 1995), as can the release of 
cytokines and/or other factors related with activation (Colton & Gilbert 1987; Sebire et al. 
1993; Romero et al. 1996).  
 
Figure 1.4. Classical “resting” and “activated” microglial phenotypes. (A) “Resting”, green fluorescent 
protein-expressing microglial cells (CX3CR1GFP/+, green) and yellow fluorescent protein-expressing neurons 
(Thy1-YFP, orange) in a P12 mouse hippocampus. Notice the thin, ramified projections of microglia. (B) The 
same cells in an in vitro hippocampal slice culture. Notice how the projections in microglial cells are scarce as 
compared to the “resting” state, the result of the activation and subsequent phenotypical shift in microglia in 
a slice culture (Stence et al. 2001). Images from the laboratory of Michael E. Dailey (Dailey 2010). 
 
Maintaining primary microglia in highly purified cultures turned out a great resource to 
study their behaviour and functions, but the fact that the yield of these cells per animal is 
low means that many animals are required to obtain a sufficient number of microglia (Imai 
et al. 2007). This makes this model more time consuming and perhaps less attractive as 
compared to other culture systems. 
 
1.2.2.3. Microglial cell lines 
 
Options were investigated to overcome the low-yield and time-consuming culture 
techniques presented thus far, in order to rapidly obtain large and homogeneous 
populations of microglial cells. Generating immortalized cell lines by infecting the cells 
with a retrovirus (Cepko 1989; Briers et al. 1994) offers a solution to this problem. 
Two commonly used cell lines of this type are the BV2 and N9 microglia cell lines which 
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are derived from rat and mouse, respectively ((Righi et al. 1989; Blasi et al. 1990), reviewed 
in (Stansley et al. 2012)). Both cell lines were assessed for typical microglia cell markers and 
tested positive for FcγRs, CD11b, F4/80 and nonspecific esterase activity, while they were 
negative for glial fibrillar acidic protein (GFAP) and galactocerebroside (markers for 
astrocytes and oligodendrocytes, respectively) (Righi et al. 1989; Blasi et al. 1990). Apart 
from structural markers, these cells exhibit functional phenotypes of microglia as well, with 
the induction of cytokine release, migration and phagocytosis in the presence of 
endotoxins such as LPS (Horvath et al. 2008; Ferreira et al. 2011; Ferreira et al. 2012a). 
These immortalized cell lines have been used to demonstrate the ability of microglia to 
change state and assume different roles in pathologies of the CNS. Despite the similarity to 
primary microglia, immortalization through transfection with oncogenes renders them in 
some ways different from primary microglia, in terms of variance of morphology or 
proliferation and adhesion (Horvath et al. 2008). But the fact that these cells have similar 
morphology and behaviour responses, and are more rapidly available and low-
maintenance when compared with alternative culture systems, makes them valuable cell 
models to help answer very specific inflammatory research questions. 
 
1.3. Microglial activation 
 
Triggering microglial activation can be effected by an array of molecules, ranging from 
structural components of microorganisms (pathogen-associated molecular patterns – 
PAMPs), to abnormal endogenous proteins or signs of tissue damage (damage-associated 
molecular patterns – DAMPs), cytokines, chemokines, antibodies, and others (reviewed in 
(Hanisch & Kettenmann 2007)). To be able to discriminate all of these (and more) signals, 
microglial cells are equipped with an enormous variety of membrane receptors which are 
involved in different aspects of the microglial response (Fig. 1.3.) (Raivich et al. 1999; 
Nimmerjahn et al. 2005). Naturally, pattern-recognition receptors (PRRs), which recognize 
PAMPs and DAMPs, are among them (Ransohoff & Brown 2012). The most notorious and 
well-studied family of PRRs is the Toll-like receptor (TLR) family, which recognizes 
conserved structures in pathogens (Kawai & Akira 2010; Lehnardt 2010). A total of 13 
TLRs have been described so far. However, TLR10 is not functional in mice, while TLRs 11 
to 13 are not present in the human genome (Kawai & Akira 2010). TLRs are activated by 
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bacterial LPS, hypomethylated DNA, flagellin or double-stranded RNAs, for example. 
TLRs activation generally initiates signalling cascades that involve the recruitment of 
myeloid differentiation primary response 88 (MyD88) and generally result in mediation of 
transcription by nuclear factor-kappa B (NF-κB) (Fig. 1.5.) (Hanamsagar et al. 2012). 
 
Figure 1.5. PAMP recognition by TLRs and subsequently activated signalling cascades. (Kawai & Akira 
2010). 
 
In addition, microglial activity can also be controlled by signals from neurons themselves. 
Neurons have classically been placed on the ‘receiving’ end of microglia’s actions, either 
endangered or protected by microglial activation (Butovsky et al. 2005). But it is now 
established that this is not the case. Neurons express their own set of agents to act upon 
microglia, which can either elicit activation or “quiescence”: an ‘on and off’ system (Biber 
et al. 2007). ‘Off’ signals are constitutively expressed in the brain, and loss of ‘off’ signalling 
is enough to drive microglia into a different functional state. Several molecules have been 
identified as ”off” signals, namely CD200 and fractalkine (Fkn, CX3CL1) constitutively 
expressed by neurons, and most neurotransmitters (except for glutamate) keep microglia 
in a non-activated state. On the other hand, “on” signals like purines, glutamate or matrix 
metalloproteinases can elicit microglial activation (Biber et al. 2007). Such a system is 
designed to tightly control microglial activity in a healthy CNS (van Rossum & Hanisch 
2004). 
Of course, not all activation signals bring about the same result in microglia (Butovsky et 
al. 2005). Depending on the state of the brain prior to the stimulus, the stimulus itself and 
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subsequent secondary events, microglia can adopt one from a spectrum of phenotypes that 
might not be readily distinguishable through morphological observation only (Perry et al. 
2010). Indeed, microglial activation has been associated with either neurodegeneration or 
neuroprotection, in a sort of Dr. Jekyll and Mr. Hyde duality (Czeh et al. 2011). Answering 
the question of whether microglial activation is detrimental or neuroprotective is not trivial 
as the line separating neuroprotective from neurotoxic responses may be very thin. 
 
1.4. Mechanisms of microglial migration 
 
Moving microglial cells follow the same basic mechanisms of migration common to 
various other cell types (fibroblasts, neuroblasts, leukocytes, etc.), in a tightly regulated 
process driven by dynamic cellular cytoskeletons (reviewed in (Ridley et al. 2003)). 
Migration is a multistep, cyclic event, in which cells acquire a spatial asymmetry, enabling 
them to turn intracellularly generated forces into net cell body translocation. Typically, 
cells become polarized within the plane of movement, upon detection of a migration-
promoting agent, extend membrane protrusions in the sought direction, and finally retract 
the cell body in the direction of the extension (Schwab 2001). Front and rear end can be 
easily distinguished. The former is a flat, organelle-free process, the so-called 
lamellipodium, while the latter is formed by the prominent cell body that extends into a 
uropod (Fig 1.6.) (Schwab 2001).  
 
Figure 1.6. Spatial asymmetry during microglial migration. Lamellipodium (right, thin) protrudes into the 
direction of movement while the uropod (left, thick) retracts into the direction of movement. Adapted 
from(Kettenmann et al. 2011) 
 
Composed by a dense meshwork of actin filaments that project from the cell surface, the 
lamellipodium is driven by actin polymerization that occurs in the direction of locomotion, 
at the leading edge of the cell. It is stabilized by the establishment of focal complexes with 
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the extracellular matrix (ECM) or adjacent cells via transmembrane receptors linked to the 
actin cytoskeleton (Ridley et al. 2003), thus providing the traction force necessary for the 
cell to move. But for migrating cells to form new contacts at its front, old contacts must be 
released at the rear, which implies that the interaction between extracellular matrix and cell 
adhesion receptors has to be a highly coordinated process (Schwab 2001). Actin-binding 
proteins play major roles in this process. (Ridley et al. 2003). 
The rates at which cells can migrate depend on cell type as well as on the communication 
with the ECM or substrate. When cells cannot form contacts with the matrix (too little 
friction), locomotion is impaired. Similarly, locomotion is also impaired when the matrix is 
too “sticky” and cells cannot release their focal complexes (Schwab 2001). The formation of 
these complexes requires integrin clustering, a process activated by talin and mediated by 
PKC, Rap1 and PI3K signalling pathways (Ridley et al. 2003), while disassembly requires 
Rho kinase and is a myosin-dependent process. Also, the rise of intra-cellular Ca2+ levels 
have been implicated in the disassembly of adhesions at the rear, through Ca2+-activated 
protease calpain, which has the potential to cleave several focal adhesion proteins (Ridley et 
al. 2003). 
Migration by chemotaxis depends on the establishment of membrane protrusions 
following a chemotactic gradient, mediated by membrane receptors of the chemotactic 
agents, which activate signal transduction pathways and mould the cytoskeleton locally in 
the direction of the gradient (Van Haastert & Devreotes 2004). In a uniform concentration 
of chemoattractant, cells move in a persistent but random direction. Differences as small as  
2–10% in the concentration of chemoattractants between the front and the back of the cell 
are enough to elicit a directed migration, whether the average level of receptor occupancy is 
small or large (Van Haastert & Devreotes 2004). Microglia have been shown to migrate in 
the presence of ATP released from damaged cells, glutamate, (endo)cannabinoids, 
microbial signals, various growth factors, β–amyloid, various cytokines and chemokines, 
among others (Kettenmann et al. 2011). 
 
1.5. Microglial phagocytosis 
 
Microglial cells are the resident professional phagocytes of the CNS, critical in its 
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protection against damage in pathology, but equally important during brain development. 
Microglial cells actively scan tissue under both normal and pathologic contexts. They play a 
specific role in removing apoptotic cells, but are also considered to be involved in synapse 
removal during development (Pont-Lezica et al. 2011). Phagocytosis is a key function for 
microglial cells, and as such, microglia display a wide range of receptors that mount a 
concerted response leading to phagocytosis and removal of cell debris (Walter & Neumann 
2009). 
Phagocytosis is the process by which the phagocyte surrounds the particle or cell to be 
engulfed with extensions of its plasma membrane; this process results in the formation of 
an intracellular vesicle called a phagosome, which contains the ingested particle (Abbas et 
al. 2012). Clearance of the phagocyted particles is achieved by fusing phagosomes with 
lysosomes, which contain several hydrolytic enzymes, thus digesting the contents of the 
new phagolysosome. Remnants are later exocyted out of the cells. Recognition of 
pathogens or cell damage-related antigens activates phagocytes, which migrate to the lesion 
site, release a wide range of soluble factors that include cytotoxins, neurotrophins and/or 
immunomodulatory factors and clear cellular debris by phagocytosis (Neumann et al. 
2009). Phagocytosis is a highly regulated process that requires high cytoskeleton dynamics. 
Phagocytic processes are driven by a controlled rearrangement of the actin cytoskeleton, in 
which actin fibers are continually assembled and disassembled in response to the local 
activity of signalling transduction systems. Networks of highly branched filaments are 
created, generating the forces involved in changing cell shape (Fletcher & Mullins 2010). 
Microglia, as well as other phagocytes, express more than one kind of phagocytic receptor. 
There are two distinct functional types of phagocytic receptors related to two different 
types of phagocytic behaviour. Stimulation of TLRs and phagocytosis of pathogens induce 
a pro-inflammatory cascade, while recognition of phosphatidylserine (PS) residues and 
clearance of apoptotic cell membranes induces an anti-inflammatory response 
(Ravichandran 2003). Removal of apoptotic material without inflammation is an essential 
and beneficial function of microglia. (Fig. 1.7.). 
Broadly, phagocytosis can occur in an opsonin-dependent or –independent manner 
(Choucair et al. 2006). Opsonin-dependent receptors, such as FcγRs and complement 
binding receptors, depend on the previous signalization of the phagocytic target by soluble 
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receptors (opsonins) for a proper phagocytic induction. Opsonisation is achieved through 
the binding of immunoglobulins (in the case of FcγRs), or complement components (in the 
case of complement receptors) to the surface of the pathogen or apoptotic structure 
targeted for phagocytosis. Opsonin-independent phagocytosis occurs for example through 
scavenger receptors, which can recognize a variety of ligands, namely acetylated or oxidised 
low-density lipoprotein, bacterial endotoxins such as lipoteichoic acid or LPS, or fibrillar β-
amyloid (Choucair et al. 2006). Upon ligand binding, scavenger receptors cluster on the 
membrane surface and induce rearrangement of the actin cytoskeleton, thereby inducing 
phagocytosis. The family of Rho guanosine triphosphatases (GTPases), which includes 
Cdc42, Rac, and Rho, link membrane receptors to the actin cytoskeleton, mediating 
phagocytosis (Choucair et al. 2006). 
 
Figure 1.7. Microglial phagocytic receptors. (Neumann et al. 2009) 
 
1.6. LPS induced activation of microglia 
 
The activation of TLR4 via LPS is perhaps the most used model to study microglial 
activation. LPS is a component of the outer cell membrane of Gram-negative bacteria, and 
it is by itself able to trigger chemical and functional responses in microglia, such as the 
release of cytokines, the induction of cytoskeleton reorganization, as well as cellular 
migration (Lee et al. 1993; Abd-El-Basset & Fedoroff 1995). This endotoxin has been 
demonstrated to activate microglia to such extent as to cause neurodegeneration in vitro 
and in vivo, without being neurotoxic by itself (Block et al. 2007). For these reasons, LPS 
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has become a gold standard to study the activation of microglia (Rivest 2003). 
LPS binding to TLR4 leads to the recruitment of MyD88, and consequently the activation 
of the downstream c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein 
kinases (MAPK) signalling pathways. Also, signalling through TLR4 with LPS recruits NF-
κB inhibitor kinase (IκK), which phosphorylates the NF-κB inhibitor (IκB). This results in 
the release of NF-κB, and its translocation into the nucleus (Kawai & Akira 2010). Both of 
these signalling cascades result in the transcription of pro-inflammatory regulators, leading 
to the activation profile exhibited by microglia in the presence of LPS: enhanced pro-
inflammatory cytokine production, cytoskeleton reorganization and enhanced mobility.  
LPS was shown to stimulate the release of IL-1β in N9 cells, which could in turn increase 
the expression of iNOS and thus the production of NO in an autocrine / paracrine fashion 
(Ferreira et al. 2010). The same LPS / IL-1β signalling was also shown to mediate the 
increase in phagocytic activity in these cells, through activation of the p38 MAPK pathway; 
inhibition of this pathway as well as of IL-1β signalling reduced the observed phagocytic 
behaviour (Ferreira et al. 2011). Finally, this same signalling cascade has also been involved 
in the increase in cell motility and in the reorganization of the cytoskeleton in N9 microglia 
stimulated with LPS (Ferreira et al. 2012a). 
 
1.7. Fractalkine-mediated regulation of microglial activity 
 
The main objective of this study is to evaluate the modulatory effect of the chemokine 
fractalkine (Fkn) on microglial activation elicited by the endotoxin LPS. Fkn, as well as its 
G protein-coupled receptor (GPCR) CX3CR1, are constitutively expressed in various non-
hematopoietic tissues, including the brain (Heinisch & Kirby 2009). It is the only member 
of the CX3C family (with cysteines separated by three amino acids) and can exist as either a 
membrane-anchored protein or a soluble glycoprotein (Kettenmann et al. 2011). Also 
differing from other chemokines, which can interact with multiple GPCRs, Fkn has only 
one cognate receptor, CX3CR1 (Imai et al. 1997). Furthermore, the two structural forms of 
Fkn, membrane-bound and soluble, enable it to act as an adhesion molecule as well as a 
chemoattractant (Bazan et al. 1997).  
What really makes this chemokine/receptor pair almost unique in the brain is their role in 
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the neuron/microglia communication. In the CNS, neurons are the primary source of Fkn, 
while CX3CR1 has been almost exclusively detected on microglial cells (Berangere Re & 
Przedborski 2006; Cardona et al. 2006). Chemokines were mostly regarded as glia-
expressed molecules in the CNS, but their expression in neurons and the expression of the 
respective receptors in microglia can contribute to neuron-microglia interactions, both 
under physiological and pathological conditions (reviewed in (de Haas et al. 2007)). The 
involvement of the Fkn–CX3CR1 axis in fundamental processes of communication 
between neurons and microglia has been proposed a long time ago (Pan et al. 1997), given 
the expression pattern of the chemokine and the receptor.  
Signalling differences were immediately noticeable between soluble and membrane-bound 
forms of Fkn, as both forms were able to elicit intracellular Ca2+ mobilization, yet this 
potential was greater for membrane-anchored Fkn, as compared to soluble forms. This 
implied a differential regulation of intracellular levels of calcium within microglia by 
neurons (Harrison et al. 1998). Shedding of membrane-anchored Fkn is regulated by 
proteases from A Disintegrin And Metaloprotease (ADAM) family, namely ADAM-10 and 
ADAM-17 (Garton et al. 2001; Tsou et al. 2001; Hundhausen et al. 2003). The former is 
responsible for the constitutive cleavage of Fkn, while ADAM-17 has been shown to 
mediate inducible cleavage of Fkn from the cell membrane. Cleavage of Fkn from cultured 
neurons is rapidly induced in response to an excitotoxic stimulus, preceding neuronal 
death (Chapman et al. 2000). Inducible shedding by neurons and differences in signalling 
activity on microglia might suggest that Fkn differentially regulates microglial activity in 
the CNS, depending on the existing homeostatic balance. Indeed, Fkn was shown to 
modulate signs of microglial activation elicited through stimulation with LPS. Microglia 
increase production of pro-inflammatory cytokines, such as TNF-α, IL-1β or IL-6, and 
reactive oxygen species (ROS), such as NO, in the presence of this endotoxin. Release of all 
of these factors was dose-dependently reduced by the stimulation with Fkn (Zujovic et al. 
2000; Mizuno et al. 2003). Notably, Fkn binding to CX3CR1 reduces proinflammatory 
cytokine expression through the induction of an increase in Akt phosphorylation, leading 
to the activation of the downstream PI3K pathway (Meucci et al. 2000; Lyons et al. 2009). 
Soluble and membrane-bound forms of Fkn might, nevertheless, exert slightly different 
effects on these intracellular signalling mechanisms (Berangere Re & Przedborski 2006). 
Signalling through CX3CR1 plays a role in shifting or diminishing microglial activation, 
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thus making it an excellent target to try and damper neurodegeneration caused by reactive 
microglia (Fig. 1.8.). 
Despite of seemingly reducing microglial activation, Fkn has been shown to induce cell 
migration in leukocytes or monocyte-derived cells (Imai et al. 1997; Ruitenberg et al. 
2008). In microglia, Fkn induces actin cytoskeleton reorganization and cell migration, in a 
mechanism dependent on the increase in intracellular Ca2+ mobilization and MAPK 
phosphorylation (Maciejewski-Lenoir et al. 1999). While increases in mobility of microglia 
have been correlated with activation, Fkn apparently shifts microglia to a state where cells 
reduce pro-inflammatory signalling but exhibit enhanced mobility. 
Phagocytic behaviour of microglia is also affected by stimulation with Fkn. In the presence 
of this chemokine, microglia up-regulate the expression of milk-fat globule EGF factor-8 
(MFG-E8), a tethering molecule that recognizes PS exposed on the surface of apoptotic 
cells (Miksa et al. 2007). Opsonizing MFG-E8 then serves as a bridging adaptor, attaching 
to integrin receptors on the surface of microglia and eliciting phagocytosis (Akakura et al. 
2004; Fuller & Van Eldik 2008). In a model of excitotoxicity caused by glutamate, the 
release of Fkn from neurons induced an increase in the expression of MFG-E8 by 
microglia, leading to enhanced phagocytic activity (Noda et al. 2011). 
 
Figure 1.7. Fkn mediated neuron-microglia crosstalk. Fkn activates the PI3K pathway, leading to a decrease 
in the release of cytokines and ROS associated to inflammation. (Berangere Re & Przedborski 2006) 
 
In vivo, deficient signalling through the Fkn/CX3CR1 system due to a knock-out of 
CX3CR1 deregulated microglial responses and aggravated inflammation in an 1-methyl-4-
Injured
neuron
Fractalkine
cleavage
ADAM 10
Activated
microglia
CX3CR1Soluble
form signaling
Fractalkine
gradient
Membrane
anchored form
signaling
Prot G
Fractalkine
Ca2+
Ca2+
Ca2+
Ca2+
iNOS
TNF-α
IL-6
MAPK
PI3K
Akt
MAPKPI3K
IL-1β
Modulatory effects of the chemokine Fractalkine in a model of endotoxin-induced microglial activation 
 18 
phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s model, resulting in 
neurotoxicity (Cardona et al. 2006). The same study also revealed increased microgliosis in 
CX3CR1-ko mice challenged with systemic inflammation induced by intraperitoneal 
injections of LPS. Moreover, CX3CR1-deficient mice also show deficits in the resolution of 
microglial activation after an LPS injection, when compared with heterozygote mice 
(Corona et al. 2010). In a model of Alzheimer’s, CX3CR1 deficiency was shown to worsen 
neuronal and behavioural deficits by enhancing Tau pathology and calbindin depletion, 
resulting in an increase in TNF-α and IL-6 expression by over-activated microglia (Cho et 
al. 2011). These reports suggest that Fkn is of great importance in the control of microglial 
activity in the case of altered brain homeostasis. 
The influence of Fkn on microglia extends beyond the regulation of these defence 
mechanisms. Microglia can easily be located in neurogenic niches, and have thus become 
interesting candidates for modulating neurogenesis in both the healthy and injured brains 
(reviewed in (Ekdahl 2012)). Signalling through CX3CR1 reportedly modulates 
hippocampal neurogenesis by regulating the levels of IL-1β. Disruption of the 
Fkn/CX3CR1 axis diminishes proliferation of neural progenitor cells in young rodents, 
while the age-related decrease in hippocampal neurogenesis due to lower levels of Fkn in 
old rats could be restored by the delivery of exogenous Fkn (Bachstetter et al. 2011). 
Considering the previously exposed considerations, we decided to study the modulatory 
effects of Fkn on microglia, using the cell line N9 as a biological model. Our hypothesis is 
that soluble Fkn is able to change the pro-inflammatory profile elicited by LPS in N9 
microglia ((Ferreira et al. 2010; Ferreira et al. 2011; Ferreira et al. 2012a; Ferreira et al. 
2012b)) to a less aggressive one, but maintaining increased migratory and phagocytic 
activities. Therefore, and given the evidence that support the modulatory role of Fkn, we 
aim to analyse the effect of this chemokine in N9 microglial cells under basal and LPS-
stimulated conditions in classical signs of microglial activation, such as: 
- Cytokine expression; 
- Morphological characteristics; 
- Phagocytic activity; 
- Migratory ability. 
 
Through this study, we set out to understand whether and how Fkn could be used to down-
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regulate negative aspects of microglial activation, which induce or exacerbate 
neurodegeneration, in order to establish a working model where Fkn can be used to protect 
CNS from over-activated microglia. 
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Chapter II - Methodology 
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2.1. Cell line culture 
 
Murine N9 microglia cell line (kind gift from Prof. Claudia Verderio, CNR Institute of 
Neuroscience, Cellular and Molecular Pharmacology, Milan, Italy) was maintained in 
Roswell Park Memorial Institute (RPMI) 1640 medium with GlutaMAX™ (#61870-010 
gibco®, Life Technologies, Carlsbad, California, USA), supplemented with 5% heat-
inactivated foetal bovine serum (#10106-169, gibco®), D-Glucose to a final concentration of 
30 mM (#G7021, Sigma-Aldrich, St. Louis, Missouri, USA), and penicillin-streptomycin 
(P/S) (100U/ml and 100μg/ml, respectively, #15140-122, gibco®). Cells were grown at 37°C 
in a 95% atmospheric air and 5% CO2 humidified atmosphere. For immunocytochemistry 
studies, cells were plated at a density of 1×104 cells per cover slip (Ø=10mm). In remaining 
experiments, cells were plated at a density of 2×l05 cells per well in 12-well trays or 5×l05 
cells per 6-well trays. The number of viable cells was evaluated by counting trypan blue-
excluding cells. 
Prior to treatment incubations, cell medium was changed from the above to Dulbecco's 
Modified Eagle Medium:Nutrient Mixture F-12 (DMEM/F-12) with GlutaMAX™ (#31331-
028, gibco®), supplemented with B-27® serum-free supplement (#17504-044, gibco®, 1:100), 
P/S (100U/ml and 100μg/ml, respectively, #15140-122, gibco®), natural mouse epidermal 
growth factor (EGF, 5μg/ml, #53003-018, Invitrogen™®, Life Technologies, Carlsbad, 
California, USA) and recombinant human fibroblast growth factor basic (bFGF, 2,5μg/ml, 
#13256-029, Invitrogen™). Cells were maintained in DMEM/F-12 for 4 hrs prior to the 
beginning of any experimental protocol to minimize unspecific stress. Cell treatment 
included the following incubation setups: LPS from Escherichia coli (055:B5, 100 ng/ml, 
#L2880, Sigma-Aldrich), Fkn chemokine domain (200ng/ml, #F2303, Sigma-Aldrich), or a 
combination of the aforementioned for 4 hrs in the case of RNA isolation, 6 hrs for western 
blotting, immunocytochemistry analysis and phagocytosis assays or 12 hrs for the motility 
assay. 
 
2.2. RNA isolation from N9 microglial cells 
 
Total RNA was isolated with Aurum™ Total RNA Mini Kit (#732-6820, Bio-Rad, Hercules, 
California, USA), using an adapted protocol based on manufacturer's instructions. Briefly, 
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cells were lysed with the provided lysis buffer supplemented with 1% β-mercaptoethanol 
(#63689, Sigma-Aldrich) by thoroughly scraping the wells. The lysate was frozen and stored 
at -20ºC. After thawing, ethanol was added to the sample tubes, followed by vortexing and 
up-and-down pipetting to ensure proper mixing. Homogenized lysates were then 
transferred to RNA binding columns and centrifuged for 1 min at 1,48×104g, the speed 
used for all centrifugations in this protocol. Samples were washed through centrifugation 
with low stringency wash solution from the kit, followed by a 15 min incubation with 5 μl 
of provided DNAse I, diluted with 75 μl of DNAse dilution solution, in order to remove 
genomic DNA contamination. Further purification and removal of organic contaminants 
was achieved through two centrifugation steps, with provided high stringency and low 
stringency wash solutions, respectively. Purified RNA samples were obtained through 
centrifugation for 2 min with the elution solution from the kit. Diluted RNA was stored at -
80ºC prior to quantification and purity analysis for further use. Quantification was 
performed by optical density (OD) measurement at 260 nm, whereas sample purity was 
analysed using the ratios OD260/OD280 and OD260/OD230 (only samples whose ratios were 
between 1.9 and 2.1 were transcribed), using a NanoDrop 2000 (Thermo Fisher Scientific, 
Waltham, Massachusetts, USA). 
 
2.3. Reverse transcription (RT) and quantitative polymerase chain reaction 
(qPCR)  
 
The extracted RNA (400 ng) of was reverse transcribed on a UnoCycler (VWR 
International, Radnor, Pennsylvania, USA) using iScript™ cDNA Synthesis Kit (#170-8890, 
Bio-Rad,) following manufacturer’s instructions. In short, reaction mix containing 
oligo(dT)s, random hexamers, dNTPs and a modified Moloney-murine leukaemia virus 
reverse transcriptase (M-MLV RT) pre-blended with RNAse inhibitor were added to the 
extracted RNA, as well as nuclease-free water to top up the volume to 20 μl. Some samples 
were submitted to the same protocol without reverse transcriptase (RT- sample) to be used 
as non-template negative controls for qPCR. Complete reaction mixes were incubated for 5 
min at 25ºC for annealing, followed by 30 min at 42ºC for extension and 5 min at 85ºC for 
melting. Generated cDNAs were stored at -20ºC until further use. 
qPCR analysis of the reverse transcription products was performed on a iQ™5 Multicolor 
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Real-Time PCR Detection System (Bio-Rad) using iQ™ SYBR® Green supermix reaction kit 
(#170-8882, Bio-Rad) following the manufacturer’s protocol. Briefly, amplification 
reactions were performed in 10 μl reaction medium containing 2.5 μl of template cDNA, 5 
μl of 2x iQ™ SYBR® Green supermix (50U/ml iTaq™ DNA polymerase, 0,4 mM 
deoxynucleotide mix and 6 mM MgCl2), forward (F) and reverse (R) primers (Table 1) and 
nuclease-free water to complete the reaction volume. Some wells contained nuclease-free 
water or RT- samples instead of cDNA as non-template samples. These non-template 
controls served as negative controls to detect possible contaminations and/or the 
amplification of genomic DNA. 
The primers used for qPCR analysis were designed using the open-source software tool 
PerlPrimer (Marshall 2004) (v. 1.1.20), except for the primers for reference genes. Primer 
pairs were designed to be exclusively complementary to the cDNA sequence of the 
individual detection target transcripts. The primers were selected according to the 
following criteria: a) melting temperature between 58 and 62ºC, with a maximum 
difference of 2ºC between forward and reverse primers; b) no more than 3 identical 
nucleotides in a row; c) GC content about 40-60%; d) a GC clamp in the 3’ end (at least 2 of 
the last 3 bases should be G or C); e) span intron-exon boundary and overlap the boundary 
by 7 bps; f) final product length between 50-200 bps and g) primer length between 18-24 
bps. 
 Table 1 – Primer sequences (F and R) used for qPCR analysis.  
Gene Tm (ºC) Amplicon 
size (bps) 
Primer sequence (5’-3’) 
IL-1β F - 60 
R - 59 
125 F - ATT AGA CAA CTG CAC TAC AGG 
R - CAT GGA GAA TAT CAC TTG TTG G 
TNF-α F - 58 
R - 58 
252 F - CTG TAG CCC ACG TCG TAG CA 
R - CGG CAG AGA GGA GGT TGA CT 
CX3CR1 F - 61 
R - 60 
100 F - ATC TGC TCA GGA CCT CAC 
R - CAA TGT CGC CCA AAT AAC AG 
MFG-E8 F - 62 
R - 63 
71 F - GAG TTG CAC GGA TGT TCT GAG 
R - GGA GGC TGA CAT CTG GCT G 
HPRT1 N/A 168 N/A 
GAPDH N/A 144 N/A 
 
The specificity of the sequence of the designed primers was checked using BLAST and was 
further investigated for the formation of primer-dimers and secondary structures (e.g. 
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hairpins). Targeted amplicons were checked for the presence of single-nucleotide 
polymorphisms with the online software tool RTPrimerDB (Pattyn et al. 2006; Lefever et 
al. 2009). Hypoxanthine-guanine phosphoribosyltransferase 1 (HPRT1) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as reference genes, and 
their respective primer sets were obtained from selected QuantiTect Primer Assays 
(#QT00166768 and #QT01658692, respectively, Qiagen, Austin, Texas, USA). qPCR 
protocol comprised two phases, an initial template denaturation/enzyme activation step at 
95ºC for 3 min, followed by 40 cycles of denaturation (95ºC, 10 s) and annealing (60ºC, 30 
s) steps. Fluorescence was determined at the end of the annealing step. Finally, melting 
curves were obtained for all samples, between 55 and 95ºC, with a temperature increase of 
0.5ºC every 10 s, with continuous fluorescence measurement. All reactions were performed 
in duplicate for each of the samples. Primer concentrations and qPCR conditions were 
optimized to obtain the minimum non-specific amplification for all primers. The specificity 
of amplification for each primer pair was confirmed by determining that the melting curve 
showed a single dissociation peak, corresponding to a single amplification product. 
Furthermore, the determined melting temperature of the amplified product should lie in 
the vicinity of the predicted melting temperature for the selected amplicon.  
 
2.4. qPCR analysis 
 
Real-time qPCR results were analysed with Relative Expression Software Tool - Multiple 
Condition Solver (REST-MCS©) version 2, which is based on the mathematical model 
proposed by Pfaffl (Pfaffl, 2001). Like other qPCR analysis methods, such as the “double-
delta Ct“ method, this model takes into account the differences of variation of threshold 
cycle (Ct) values between one (or more) reference genes and genes of interest, in control 
(baseline) versus experimental (treated) samples. Importantly, this method further takes 
into account the mean amplification efficiencies of the qPCR reactions for the selected 
amplicon/primer pair as well, in order to calculate the fold variation in expression ratios of 
genes of interest as compared to reference genes. By factoring in the amplification 
efficiency instead of assuming that the theoretical 100% efficiency holds true, this method 
yields more consistent results than comparative Ct or double-delta Ct methods. 
Amplification efficiencies for each amplicon and Ct values for each particular reaction were 
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determined with LinRegPCR (Ramakers et al., 2003; Ruijter et al., 2009). LinRegPCR uses 
an unbiased linear regression algorithm to analyse the raw (i.e. non-baseline corrected) 
data generated with the thermal cycler for each sample and to determine optimal baselines, 
Ct values and estimate amplification efficiencies based on the log-linear phase of the 
amplification reactions. REST-MCS© was then used to analyse differences between groups, 
with a non-parametric randomisation test (Pair Wise Fixed Reallocation Randomisation 
Test©). The advantage of this test lies in its independence of assumptions about the 
distributions of experimental data, while remaining as powerful as more standard statistical 
tests, such as analysis of variance tests (Pfaffl et al., 2002). 2000 iterations of the Pair Wise 
Fixed Reallocation Randomisation Test© were run for each condition pair to determine 
how likely the differences between group means were to be greater in the case of a random 
allocation than those observed. Results were considered statistically significant for p values 
< 0.05. Data were presented as percentage of control ± standard error of mean (SEM). 
 
2.5. Western blotting 
 
Protocol for western blotting was used as previously described (Ferreira 2012). Briefly, to 
obtain total protein extracts, cells were incubated with lysis cocktail solution (75 mM NaCl, 
#31434, Sigma-Aldrich, 25 mM Tris, #T1378, Sigma-Aldrich, 2.5 mM EGTA, #E4378, 
Sigma-Aldrich, 0,5% Triton X-100, #BP151-500 Thermo Scientific, 6.03 mM DOC, 
#D6750, Sigma-Aldrich, 1.73 mM SDS, #161-0302, Bio-Rad, 0.05 mM DTT, D9779, Sigma-
Aldrich and cOmplete, Mini Protease Inhibitor Cocktail, #11836153001, Roche Applied 
Science, Penzberg, Germany) (pH 7.5), and gently homogenized. Samples were then 
centrifuged for 20 min at 4300×g and 4°C, the supernatant collected, and the total amount 
of protein was quantified using the BCA assay (#23225, Thermo Scientific). 50 μg per 
sample were then loaded onto 5% stacking / 10% resolving acrylamide/bisacrilamide gels 
(#161-0158, Bio-Rad) and separated by SDS-PAGE using a bicine (#B3876, Sigma) / SDS, 
Bio-Rad) electrophoresis buffer (pH 8.3), at constant voltage (120 V) for 2 hrs at room 
temperature. After separation, proteins were transferred to PVDF methanol-activated 
membranes (#IPVH00010, Millipore Corporation, Billerica, Massachusetts) with 0,45 μm 
pore size under the following conditions: constant amperage (300 mA), 90 min at 4°C in a 
solution containing 10 mM CAPS (#C2632, Sigma-Aldrich) and 20% methanol 
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(#20903.368, VWR International) at pH 11.0. Membranes were blocked in Tris-buffer 
saline (TBS, 15 mM Tris, #T1378, Sigma, 150 mM NaCl, Sigma, pH 7.6) containing 5% w/v 
bovine serum albumin (BSA, #SC-2323, Santa Cruz Biotechnology, Santa Cruz, California, 
USA) and 0.1% v/v Tween® 20 (#P5927, Sigma-Aldrich) for 1 hr, at room temperature, and 
then incubated overnight at 4°C with the primary antibody solution (rabbit polyclonal 
anti-CX3CR1 #14-6093-81, eBioscience, San Diego, California, USA) diluted in TBS-T 
(TBS, 1% v/v Tween® 20, Sigma-Aldrich), 5% BSA. After rinsing three times with TBS-T, 
membranes were incubated for 1 hr at room temperature with an alkaline phosphatase-
linked goat anti-rabbit IgG (#65-6122, novex®, Life Technologies) 1:10,000, in TBS-T with 
5% w/v BSA. Protein immunoreactive bands were visualized in a Versa-Doc 3000 Imaging 
System (Bio-Rad), after incubation of the membrane with ECF chemifluorescent reagent 
(#RPN5785, GE Healthcare Life Sciences, Uppsala, Sweden) for 5 min. 
 
2.6. Immunocytochemistry 
 
Cells were washed with phosphate-buffered saline pH 7.4 (PBS) (137 mM NaCl, Sigma-
Aldrich, 2.7 mM KCl, #1.04936, Merck KGaA, Darmstadt, Germany, 10 mM Na2HPO4, 
Panreac Química S.L.U., Barcelona, Spain, 2 mM KH2PO4, Merck) (3 × 5 min), fixated for 
30 min with 4% buffered paraformaldehyde (PFA) (#P6148, Sigma-Aldrich), rinsed again 
in PBS (3 × 5 min) and then placed for 30 min at room temperature in a blocking solution 
containing 3% bovine serum albumin (BSA, #SC-2323, Santa Cruz Biotechnology, Santa 
Cruz, California, USA) and 0.2% Triton X-100 (Thermo Fisher Scientific) diluted in PBS. 
Incubation with primary antibodies in blocking solution was performed overnight at 4°C 
in a humid chamber. Cells were washed with PBS (3 × 5 min) and incubated for 1 hr at 
room temperature with the corresponding secondary antibodies in PBS, as well as Hoechst 
33342 (2 μg/ml, #H3570 Molecular Probes®, Life Technologies, Carlsbad, California, USA) 
for nuclear labelling. Finally, coverslips were mounted in Fluoroshield mounting medium 
(#ab104135, Abcam, Cambridge, UK).  
Fluorescent images were acquired using a confocal LSM 510 Meta microscope (Carl Zeiss, 
Göttingen, Germany). For every immunocytochemistry analysis, at least 6 independent, 
randomly chosen microscopy fields were acquired, per coverslip, with a 40× magnification 
objective. Controls without primary antibodies were performed for each experiment, to 
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exclude non-specific labelling. Primary antibodies were used as listed: rat monoclonal anti-
CD11b (1:500) (#MCA711, AbD Serotec, Oxford, UK) and rabbit polyclonal anti-CX3CR1 
(eBioscience) in blocking solution. The presence of primary antibodies was revealed by 
using the following fluorochrome-conjugated antibodies diluted at 1:200 in PBS: Alexa 
Fluor 488 donkey anti-rat IgG (#A21208, Molecular Probes®) and Alexa Fluor 594 donkey 
anti-rabbit IgG (#A21207, Molecular Probes®). Membrane ruffling was visualized using a 
fluorochrome-conjugated phalloidin, which specifically binds to filamentous actin (F-
actin). Cells were incubated for 2 hrs in phalloidin-Alexa Fluor 594 conjugate (1 U/ml) 
(#A12381, Molecular Probes®) in PBS, at room temperature. 
 
2.7. Bead phagocytosis assay 
 
Latex beads (Ø=3μm, 2.08×1010 beads/ml, #LB30, Sigma-Aldrich) were opsonised with IgG 
from rabbit serum (10 ng/ml, #I8140, Sigma-Aldrich), under constant agitation at 4 rpm 
overnight at 4°C. Beads were then resuspended in previously heated DMEM/F-12 and 
distributed by each well at a density of 2×106 beads per well. After 1 hr of incubation, cells 
were washed with PBS, fixed with buffered 4% PFA for 20 min at room temperature and 
rinsed again in PBS. Beads were labelled with secondary antibody Alexa Fluor 594 donkey 
anti-rabbit IgG (#A21207, Molecular Probes®) 1:200, in PBS). For nuclear labelling, cell 
preparations were stained with Hoechst 33342 (2 μg/ml) in 0.3% BSA, 0.1% Triton-X100 
solution, for 5 min at room temperature (RT) and mounted in Fluoroshield mounting 
medium.  
Fluorescent images were acquired using an Axio Observer.Z1 microscope (Carl Zeiss). 
Each experimental condition was performed in triplicate and at least 12 images were 
acquired for each replicate. Photomicrographs were analysed with NIH ImageJ Software 
(Schneider et al. 2012), and for each image four parameters were determined: the total cell 
number, the total bead number, the total number of phagocyting cells and the total number 
of internalised beads. Only negative-labelled beads were considered as internalised, as 
assumed that secondary antibody could not reach intracellular bead Analysis was carried 
out with a designed, particle-counting macro, ensuring that only sphere-shaped signals 
which displayed a fluorescence intensity moderately higher than background were taken 
into account. Visual confirmation was used whenever the automated determination yielded 
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abnormal results. Protocol adapted from (Ferreira et al. 2011) 
  
2.8. Motility assay (Scratch wound assay) 
 
Before cell seeding, two parallel lines were carved on the underside of each well with a 
scalpel. These lines, together with the line given by the scratch wound, served as a guidance 
axis for image acquisition. Cell monolayer was approximately 95% confluent before the 
motility assay took place. The performed wound was a scratch in the monolayer, 
perpendicular to the lines carved on the underside, made with a P10 pipette tip. 
Immediately after performing the scratch, wells were slowly and carefully washed twice 
with sterile PBS, in order to remove cells released by the scratching procedure, and 
DMEM/F-12 with LPS, Fkn or both (see cell line section) was added to the cells. Two 
regions were photographed per well with an inverted Axiovert 200 microscope (Carl Zeiss), 
using a 5× objective and a CoolSNAP digital camera (Roper Scientific, Tucson, Arizona, 
USA). Cells were allowed to migrate into the scratch wound for 12 hrs and image 
acquisition was repeated in the same two areas per well. Differential interference contrast 
(DIC) images were acquired using MetaFluor Software (Universal Imaging, Downingtown, 
Pennsylvania, USA) and analysed with NIH ImageJ Software (Schneider et al. 2012). Cell 
migration was determined by counting the number of cells that migrated towards the 
middle of the wound during the period of treatment. Each experimental condition was 
performed in triplicate and 4 images (2 at t0 and 2 at t12) were acquired for every replicate. 
Protocol as described in (Ferreira et al. 2012a). 
 
2.9. Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism 5.0a (GraphPad Software, San 
Diego, California, USA) except for qPCR (see qPCR analysis). Statistical significance was 
determined by two way analysis of variance (ANOVA) followed by Bonferroni post hoc test 
for comparison among experimental settings. Statistical significance was considered 
relevant for p values < 0.05. Data were presented as means ± standard error of the mean 
(SEM). 
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Chapter III – Results 
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3.1. Analysis of the fractalkine receptor (CX3CR1) expression and regulation 
in the murine N9 microglial cell line 
 
The N9 microglial cell line has been used as an experimental model to study the molecular 
biology and function of microglia. Thus, we carried out our work with this cell line to 
explore the modulatory effect of the chemokine Fkn in a model of endotoxin-induced 
microglial activation. Considering the lack of reports analysing the expression of Fkn 
receptor CX3CR1 by this cell line, we decided to study the presence of CX3CR1 mRNA and 
protein in our N9 microglial cell cultures. 
First, CX3CR1 mRNA expression was evaluated with a qPCR protocol. Samples from 
negative reverse transcription reactions (no amplification controls, NACs) and no template 
controls (NTCs) were used as negative controls. Evaluation of the melting curves generated 
after the amplification reactions (Fig. 3.1. A) revealed a single peak at 81,5ºC. No significant 
variations in the fluorescence were observed in the reactions of negative controls. This data, 
while taking into account the specificity of the amplicon selected for cx3cr1, strongly 
suggests that the cx3cr1 gene is transcribed by N9 microglia. Furthermore, we evaluated 
whether LPS or Fkn induced changes in the expression levels of CX3CR1 mRNA in N9 
cells. Our results indicate that CX3CR1 mRNA levels did not show significant differences 
throughout all experimental conditions 4 hrs after treatment with Fkn, LPS or both 
together (Fig. 3.2.). 
We also assessed CX3CR1 protein expression through western blotting and 
immunocytochemistry techniques. Our western blotting analysis showed three specific 
bands for CX3CR1, with MWs of 40, 50 and 55 kDa respectively (Fig. 3.1. B). Such pattern 
of CX3CR1 expression has been previously described (Yang et al. 2007; Donnelly et al. 
2011). Immunofluorescence staining for CX3CR1 also demonstrated the expression of Fkn 
receptor under basal conditions in N9 microglia. CD11b, a well-established microglial and 
mononuclear phagocyte marker, was used to reveal cell morphology (Fig. 3.1. C, D). 
Almost all cells in our basal culture conditions showed expression of CX3CR1, while 
negative controls showed just a weak background staining. 
Our data indicates that there is a constitutive expression of CX3CR1 at mRNA and protein 
levels, suggesting that this cell line should respond to Fkn treatment. Therefore, we 
considered that N9 microglial cell culture is an excellent in vitro model to analyse the 
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modulatory effect of Fkn in the activation profile of microglial cells under inflammatory 
conditions. 
 
Figure 3.1. Analysis of CX3CR1 expression in the N9 microglial cell line. (A) Representative melting curves 
obtained from N9 microglial cells cDNA (green) or negative template samples (red and blue). (B) Western 
blot of 50 μg whole cell extracts from N9 cells resolved on a 10% SDS-PAGE gel revealed with anti-CX3CR1 
(1:1000). Three bands were observed, at 40, 50 and 55 kDa. (C) Representative confocal microscopy 
photomicrograph of N9 microglial cells stained for CX3CR1 (green) and CD11b (red) under basal (control) 
conditions. Cell nuclei were stained with Hoechst 33342 (blue) (D) Magnification of the highlighted area in 
(C). Scale bar: 50 μm. 
 
 
Figure 3.2. Quantification of CX3CR1 mRNA expression changes induced by LPS (100 ng/ml) and Fkn 
(200 ng/ml). qPCR analysis revealed no significant variations in CX3CR1 mRNA levels throughout all 
experimental conditions. Data are expressed as mean ± SEM (n=3) and as a percentage of control. Results 
were analysed using Pair Wise Fixed Reallocation Randomisation Test©. 
 
Modulatory effects of the chemokine Fractalkine in a model of endotoxin-induced microglial activation 
 32 
3.2. Fkn decreases mRNA levels of the pro-inflammatory cytokines IL-1β and 
TNF-α in LPS stimulated N9 microglial cells 
 
Fkn has been shown to lower microglial activation and pro-inflammatory cytokine 
expression [(Zujovic et al. 2000; Mizuno et al. 2003; Lyons et al. 2009)]. Considering this 
data we analysed the effect of Fkn on the expression levels of IL-1β and TNF-α mRNA in 
N9 microglial cells at a dilution that has been previously demonstrated to be effective (200 
ng/ml) (Lyons et al. 2009). 
Our results showed that stimulation with LPS triggered a great increase in IL-1β and TNF-
α mRNA expression, though more noticeable in the case of the former (IL-1βCTRL=100.00 ± 
12.17%, IL-1βLPS=2079.14 ± 431.76%, p ≤ 0.001; TNF-αCTRL=100.00 ± 22.18%, TNF-
αLPS=402.92 ± 110.78%, p ≤ 0.01; n=3, Fig. 3.3). Fkn treatment did not significantly change 
mRNA levels for both cytokines (IL-1βFkn=83.61 ± 14.79%; TNF-αFkn=90.02 ± 20.79%, p > 
0.05) under basal conditions. However, Fkn induced a 50% decrease on the mRNA levels of 
both cytokines upon stimulation of N9 cells with LPS (IL-1βLPS+Fkn=993.75 ± 116.15%, p ≤ 
0.001; TNF-αLPS+Fkn=216.18 ± 45.12%, p ≤ 0.05). Our results are in agreement with previous 
reports demonstrating that Fkn downregulates the increase on the expression of IL-1β and 
TNF-α mRNAs induced by LPS. 
 
Figure 3.3. Fractalkine lowers LPS-induced cytokine expression. (A) IL-1β and (B) TNF-α mRNA 
expression was induced in the presence of LPS (100 ng/ml), while it did not vary with Fkn (200 ng/ml) alone. 
Co-incubation with LPS and Fkn resulted in a significant decrease in mRNA levels when compared to LPS. 
Data are expressed as mean ± SEM (n=3) and as a percentage referred to control levels. **p ≤ 0.01, ***p ≤ 0.001 
vs control; #p ≤ 0.05, ###p ≤ 0.001 vs LPS, using Pair Wise Fixed Reallocation Randomisation Test©. 
 
3.3. Fkn modulates Fc receptor-mediated phagocytosis by microglial cells 
 
Fkn has been described to induce opsonin-dependent phagocytosis via MFG-E8 expression 
(Noda et al. 2011). Nevertheless, and to the best of our knowledge, there is no data 
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available about the effect of Fkn in FcγR-mediated phagocytosis, while LPS is known to 
increase this type of phagocytic activity (Ferreira et al. 2011). Thus, we analysed FcγR-
mediated phagocytic activity of N9 microglia after LPS and/or Fkn treatment, using a well-
established essay in our laboratory based on IgG-coated latex beads (Ferreira et al. 2011).  
 
Figure 3.4. Fkn modulates bead phagocytosis by microglial cells. (A) Representative photomicrographs 
from every experimental condition. Phagocyted beads are not stained (arrows) while non-phagocyted beads 
show a fluorescent red staining (B) LPS (100 ng/ml) led to an increase in the total number of phagocyted 
beads, as compared to control. Fkn (200 ng/ml) did not show any overall effect but reduced the percentage of 
beads phagocyted on LPS treated cells. (C) LPS and Fkn increased the proportion of phagocyting cells but did 
not show any additive effect. (D) LPS induced a greater phagocytic activity per cell, whereas Fkn presumably 
reduced this effect. Data are expressed as mean ± SEM (n=3). ** p ≤ 0.01, vs respective condition without Fkn, 
# p ≤ 0.05 ## p ≤ 0.01 and ### p ≤ 0.001 vs basal conditions (–LPS –Fkn), using two-way analysis of variance 
(ANOVA) with Bonferroni’s multiple comparison post hoc test. 
 
Stimulation with LPS induced a 1.5 fold increase in the fraction of phagocyted beads 
(CTRL=41.94 ± 1.54%; LPS=63.90 ± 1.03%; p < 0.001, Bonferroni post hoc test ; n=3; Fig. 
3.4. B), doubled the percentage of phagocyting cells (CTRL=100 ± 3.93%; LPS=206.78 ± 
5.96%; p < 0.001; Fig. 3.4. C), and also augmented the number of beads phagocyted per cell 
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(CTRL=100 ± 2.79%; LPS=142.85 ± 18.04%; p < 0.05, Fig. 3.4. D), when compared to 
control conditions. Interestingly, Fkn alone stimulated FcγR-mediated phagocytosis as 
demonstrated by the increase in the fraction of phagocyting cells (FKN=182.08 ± 8.82%;  
p < 0.01; Fig. 3.4. C). However, no significant overall effect due to Fkn was detected on the 
general percentage of phagocyted beads or the mean number of phagocyted beads per cell. 
Nevertheless, Fkn leads to a reduction of the percentage of phagocyted beads in LPS-
stimulated cells (interaction LPS*Fkn, p = 0.0001, two-way ANOVA). Furthermore, the 
LPS-mediated increase in the mean number of beads phagocyted per cell is apparently 
diminished by Fkn treatment (Fig. 3.4. D). This data indicates that Fkn is able to increase 
FcγR-mediated phagocytosis mainly by increasing the proportion of phagocyting cells. 
Moreover, despite further studies being needed to completely address the specific effect of 
Fkn on FcγR-mediated phagocytosis, our data suggests that this chemokine modulates 
LPS-induced phagocytosis on N9 microglial cells. 
 
3.4. Fkn induces cytoskeleton reorganization in microglia 
 
Although in vitro “resting” microglia does not show the typical ramified morphology of 
CNS microglial cells, classical activating agents like LPS induce their morphological 
reorganization (Abd-El-Basset & Fedoroff 1995). Indeed, pro-inflammatory cytokines, 
such as IL-1β and TNF-α, can promote F-actin rearrangement and “membrane ruffling” 
(Abd-El-Basset et al. 2004). Considering our previous data, we investigated the effects of 
Fkn on the morphological signs of activation in N9 microglial cells. 
In basal (control) conditions, N9 microglial cells showed a slim cell body mainly 
characterized by a single (unipolar) or a pair of processes (bipolar or spindle-like), 
projecting from the opposing poles of the cell body. We also observed also some cells with 
a more ramified morphology displaying radial but long and slim processes (Fig. 3.6., top 
panel). As expected, LPS induced swelling and loss of ramified morphology in N9 
microglia. Membrane “ruffles”, thick protrusions of the cell membrane formed due to F-
actin polymerization, were frequent in LPS stimulated cells, usually a sign of microglia 
activation (Fig. 3.6., second panel). Interestingly, microglia displayed a ramified 
morphology in the presence of Fkn, with numerous filopodia-like structures protruding 
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from the surface, which could loosely be described as a dendritic-like morphology 
(Butovsky et al. 2006) (Fig. 3.6., third panel). In the presence of both LPS and Fkn, N9 cells 
displayed an intermediate morphology characterized by the presence of thick membrane 
“ruffles”, but also have many thin, finger-like protrusions which extend from the primary 
branches (Fig. 3.6., bottom panel). 
 
Figure 3.5. Fkn induced cytoskeleton reorganization in microglia. Representative confocal 
photomicrographs were taken to assess the role of Fkn on the rearrangement of the actin cytoskeleton. 
Microglial cells treated with LPS (100 ng/ml) showed significant membrane ruffling (arrows), while Fkn (200 
ng/ml) induced a prominent ramified morphology characterized by thin filopodia-like structures 
(arrowheads). The simultaneous presence of Fkn and LPS resulted in an intermediate morphology. Right 
column displays magnifications of the highlighted areas in the images on the left. Cells were stained for actin 
(in red), CD11b (in green) and Hoechst 33342 (nuclei in blue). Scale bars 50 μm. 
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This data demonstrates that Fkn has an important regulatory effect on the profile of 
microglial activation, which is clearly manifested at the morphological level. 
 
3.5. Fkn promotes microglial motility 
 
The increase in IL-1β and TNF-α release, mediated by LPS, has been described to enhance 
microglial motility in an autocrine/paracrine way (Bellavance & Rivest 2012; Ferreira et al. 
2012a). Curiously, Fkn is a chemoattractant (Bazan et al. 1997; Pan et al. 1997) but reduces 
the expression of IL-1β and TNF-α. We, therefore, studied the effect of Fkn on the 
migratory activity of N9 cells under basal conditions and LPS stimulation. A scratch 
wound assay was used to analyse cell motility (Ferreira et al. 2012a), determined according 
to the mean number of cells that migrated into the wound in a 12 hr period (Fig. 3.6.).  
 
Figure 3.6. Fkn promotes microglial motility. (A) Representative photomicrographs illustrate the migratory 
stimulus induced by LPS (100 ng/ml) and Fkn (200 ng/ml). (B) LPS induced cell motility, while Fkn had a 
greater effect than LPS. Co-incubation with LPS and Fkn resulted in a greater migratory induction than that 
observed with LPS or Fkn alone. Data are expressed as mean ± SEM (n=6) and as a percentage of control. *** p 
≤ 0.001, vs respective condition without Fkn, ### p ≤ 0.001 vs basal conditions (–LPS –Fkn), using two-way 
analysis of variance (ANOVA) and Bonferroni’s multiple comparison post hoc test. 
 
Both LPS and Fkn produced extremely significant overall effects on the migratory activity 
of N9 cells (p < 0.0001 in both cases, two-way ANOVA). As expected, the presence of LPS 
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in the medium induced a greater mobilization of cells towards the gap (CTRL=100 ± 
5.84%, LPS=140.51 ± 9.37%, p < 0.001, Bonferroni post hoc test, n=6). Interestingly, the 
number of migrating cells was also significantly increased by the presence of Fkn 
(Fkn=170.10 ± 10.48%, p < 0.001, n=6), when compared to control. Finally, Fkn further 
induced an increase in mobility in LPS-stimulated cells (LPS+Fkn=200.11 ± 10.03%, p < 
0.001 n=6), a merely additive effect due to the presence of both stimuli (interaction 
LPS*Fkn, p=0.4238, two-way ANOVA). These results demonstrate that Fkn increased 
migration of N9 microglia in basal conditions and also after LPS challenge.  
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Chapter IV – Discussion 
 
  
Modulatory effects of the chemokine Fractalkine in a model of endotoxin-induced microglial activation 
 39 
Microglial cells respond to altered homeostasis in the CNS by switching their functional 
phenotype to ‘activated’, migrating to the origin of the insult, eliminating pathogens or 
debris and releasing neurotoxic and/or neurotrophic factors to return the brain 
parenchyma back to a steady state (Block et al. 2007). Failed regulation of microglial 
activity can result in an over-reactive microgliosis, which can in turn be detrimental to the 
physiology and function of the brain (Block et al. 2007). In this context, the chemokine Fkn 
emerged as a highly attractive molecule with the ability to modulate microglial response, 
avoiding or ameliorating their possible negative effects.  
In the present work, we sought to determine the effects of Fkn on different characteristics 
of N9 microglial cells, in basal conditions and after activation induced by LPS. Thus, we 
analysed several parameters, by means of qPCR, protein detection, immunofluorescence 
staining and functional assays to establish the role of Fkn. Our first results showed that N9 
microglial cells express the Fkn receptor CX3CR1, thus indicating that these cells are able to 
respond to Fkn stimulus. This was confirmed in following experiments, which demonstrate 
that Fkn reduces mRNA expression levels of the pro-inflammatory cytokines IL-1β and 
TNF-α in LPS-treated N9 microglial cells. Furthermore, we also observed that Fkn 
promotes morphological changes, migration and phagocytic activity in N9 cells. 
Altogether, our data indicates that Fkn induces a change in the activation profile of 
microglia, modulating the pro-inflammatory effect of LPS challenge while maintaining 
desired effects like increased migratory and phagocytic capacities.  
 
4.1. Expression of CX3CR1 in the murine N9 microglial cell line 
 
Since no data on the expression of CX3CR1 by the N9 cell line was available, we first 
demonstrated the expression of this receptor in this cell line using qPCR, Western blotting 
and immunofluorescence staining (Fig. 3.1.). While the theoretical molecular weight (Mw) 
for CX3CR1 is of 40.26 kDa (as calculated with ExPASy Compute pI/Mw tool (Bjellqvist et 
al. 1993; Bjellqvist et al. 1994), using the UniProtKB entry Q9Z0D9 for the murine CX3CR1 
complete protein sequence), our western blotting analysis showed three specific bands for 
CX3CR1, with Mws of 40, 50 and 55 kDa respectively (Fig. 3.1. B). Such pattern of CX3CR1 
expression has been demonstrated previously (Yang et al. 2007; Donnelly et al. 2011), 
although there is not any definitive explanation for it. Hypothetical justifications for this 
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include the expression of multiple isoforms of CX3CR1 in mice, as described for its human 
counterpart (Garin et al. 2002; Garin et al. 2003), and/or post-translational modifications. 
Expression of CX3CR1 indicates that N9 microglia should respond to Fkn treatment, as 
clearly demonstrated in further experiments.  
Contrary to what has been previously reported, we did not observe any significant change 
in CX3CR1 mRNA expression levels in the presence of LPS or Fkn. Indeed, CX3CR1 
mRNA levels have been reported to be reduced (Wynne et al. 2010), unaltered (Mizuno et 
al. 2003), or increased (Chu et al. 2009), depending on the experimental paradigm of 
microglial activation or the time post treatment at which the analysis is conducted. Despite 
no changes in mRNA levels of CX3CR1 were observed, the expression levels of the protein 
seemed to be enough to elicit a response by the binding of Fkn, as further demonstrated. 
Thus, we considered N9 cells as a good model to dissect the direct effects exerted by soluble 
Fkn in microglial cells, whether maintained in a “non-activated” basal state or after 
stimulation with LPS. This system allows us to analyse direct Fkn effects on microglia, 
without the interference of other cellular or molecular elements that could complicate the 
interpretation of the results.  
 
4.2. Fkn induced down-regulation of pro-inflammatory cytokine expression 
 
Two main pro-inflammatory cytokines, IL-lβ and TNF-α, have been involved in the 
induction of neuronal loss (Gayle et al. 2002) and are reportedly elevated in models of 
neurodegenerative diseases ((Patel et al. 2005; Cunningham et al. 2009), reviewed in 
(Viviani et al. 2004; Sugama et al. 2009)). LPS induced large increases in the expression of 
the mRNA for both of these molecules, as expected. Co-incubation with LPS and Fkn 
resulted in a significant decrease in mRNA levels when compared to LPS, which is in 
accordance with published results (Zujovic et al. 2000; Mizuno et al. 2003; Lyons et al. 
2009).  
Signalling through Fkn leads to a reduction in the expression of pro-inflammatory factors, 
thus, it stands to reason that Fkn exerts neuroprotective effects through the regulation of 
microglial production of cytokines. This has been proposed before (Mizuno et al. 2003), 
and has been observed in different models of neurodegenerative diseases in vivo ((Cardona 
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et al. 2006; Bhaskar et al. 2010; Pabon et al. 2011), reviewed in (Khandelwal et al. 2011)). 
Despite of just having analysed the effect of Fkn on mRNA expression levels, our data 
indicates that Fkn induces an anti-inflammatory effect on N9 microglial cells by 
moderating the LPS-mediated increase of pro-inflammatory cytokines. We will confirm 
our ideas in future essays aimed to analyse protein levels of IL-lβ and TNF-α and their 
receptors, as well as a larger panel of other molecules related with inflammatory responses 
(e.g. IL-6, IL-10, iNOS, etc.). 
 
4.3. Fkn modulates Fc receptor-mediated phagocytosis 
 
Many, if not all, neurodegenerative diseases show neuroinflammatory changes. Indeed, 
these disorders are associated with marked alterations in microglial distribution, numbers 
and activation state (El Khoury 2010). Neuronal death prompts reactive microgliosis, 
which can in turn drive progressive neurotoxicity (Block et al. 2007). The removal of 
apoptotic material without further inducing inflammation is then essential for the outcome 
of these disorders. Fkn has been shown to induce opsonin-dependent phagocytosis 
through the increased expression of MFG-E8, alongside releasing neuroprotective signals 
and reducing inflammation (Noda et al. 2011). Here, we investigated phagocytosis 
mediated by a different opsonin-dependent mechanism, namely through FcγRs. LPS 
treatment is known to induce FcγR-mediated phagocytosis of IgG-coated beads in N9 cells 
(Ferreira et al. 2011), but the effect of Fkn on this kind of phagocytosis by microglia had 
not yet been addressed.  
Interestingly, we observed that the presence of Fkn increased the number of cells engaging 
in FcγRs-mediated phagocytic activity, but not the predisposition of individual cells to 
phagocyte more IgG-coated beads (however, these data should be confirmed by further 
analysis in the future). Taking into account the reduction in the expression of 
inflammatory cytokines, as well as the morphological restructuring (which will be 
discussed further on) elicited by Fkn, it is plausible to suggest that Fkn induces a less 
reactive, heightened-awareness state in microglia. In this state, microglial cells are prone to 
engage in defensive actions such as phagocyting opsonized particles, while moderating 
inflammatory signalling (Neumann et al. 2009).  
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4.4. Fkn induces cytoskeleton reorganization in microglia 
 
Cytoskeleton reorganization is crucial for cell shape alterations, on which activities such as 
lamellipodial and filopodial protusion, vesicle and organelle motility, chemotaxis and 
phagocytosis all intrinsically depend (Fletcher & Mullins 2010). Activating agents, such as 
LPS, but also inflammatory cytokines such as TNF-α or IL-1β have been shown to induce 
reorganization in the actin cytoskeleton in microglia (Abd-El-Basset & Fedoroff 1995; 
Kloss et al. 2001; Abd-El-Basset et al. 2004). This can, at least in part, contribute to the 
increased rate of phagocytosis observed by activated microglia (Ferreira et al. 2011). Fkn 
has been shown to elicit actin polymerization and cytoskeletal rearrangement in dendritic 
cells (Dichmann et al. 2001) and in microglia (Maciejewski-Lenoir et al. 1999), but the 
effect of Fkn on the cytoskeleton of endotoxin-activated microglial cells has not been fully 
addressed so far. 
We observed that N9 microglia exhibited significant membrane ‘ruffling’ in the presence of 
LPS, as was expected (Ferreira et al. 2011). Curiously, the presence of Fkn induced a 
densely ramified, dendritic-like morphology. Such a phenotypical manifestation has been 
shown before in a primary culture of mouse microglia, although through the use of anti-
inflammatory cytokine IL-4 (Butovsky et al. 2006). As is the case with Fkn-treated N9 cells, 
IL-4 stimulated microglia maintains phagocytic activity (Butovsky et al. 2006), and its 
appearance more closely resembles the ramified morphology displayed by ‘surveying’ or 
‘resting’ microglia in vivo (Kettenmann et al. 2011). In our case, the change in morphology 
might correlate with the higher frequency of phagocyting cells exhibited in the presence of 
Fkn. The increase in ramified protrusions can reflect a higher ‘reconnaissance’ activity by 
these cells, which might increase the probability of an encounter with a phagocytic target, 
yet keeping the bias to engulf opsonized particles at the same level of unstimulated 
controls. Thus, Fkn plays a major role in regulating the activity profile of N9 microglia, 
which is clearly manifested at the morphological level. 
 
4.5. Fkn promotes microglial motility 
 
When activated, microglial cells display enhanced mobility (Abd-El-Basset & Fedoroff 
1995; Horvath et al. 2008). This capacity is essential to deal with and resolve insults to the 
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brain parenchyma (Noda & Suzumura 2012). Enhanced migratory activity can be due to 
the autocrine or paracrine effect of pro-inflammatory mediators, e.g. cyto- and 
chemokines, released by microglia in response to such challenges (Bellavance & Rivest 
2012; Ferreira et al. 2012a). In contrast, Fkn reduces the expression of these pro-
inflammatory mediators, which could result in reduced cell migration. This is however not 
the case, as Fkn was shown to stimulate migration in monocyte-derived cells (Imai et al. 
1997; Ruitenberg et al. 2008) and in microglia (Maciejewski-Lenoir et al. 1999; Carter & 
Dick 2004).  
Our results confirm that Fkn induces a great mobilization in microglia, independently of 
the presence of LPS (which also stimulated migration, as expected). The simultaneous 
effects of both stimuli do not show any signs of synergy nor destructive interference, 
portraying merely the addition of the isolated effect of each stimulus. This hints at probably 
separate signal transduction mechanisms at the intracellular level, with the signalling 
pathway activated by Fkn displaying a relative degree of independence from the p38 
MAPK pathway activated by LPS and IL-1β to elicit migration (Ferreira et al. 2012a). In the 
light of the reduction of TNF-α and IL-1β expression by N9 cells in the presence of Fkn, 
the increased capacity for mobilization in the presence of both pro-inflammatory stimuli 
and Fkn is of even greater relevance to the surveillance activity discussed above. 
 
4.6. Functional implications of Fkn effects in N9 cells  
 
The differences between the basal state of any type of microglial cell used as in vitro model 
to study neuroinflammation and the regular, ‘quiescent’, phenotype displayed by microglia 
in vitro are evident and have been thoroughly laid out before. But taking together data 
from the literature and provided from the observations analysed in this work, it becomes 
clear that Fkn serves, at least in part, to shorten the gap between the typical morphology 
and behaviour of microglia in vivo and that displayed by most in vitro models. Fkn has a 
clear role in reducing or shifting the activation of microglial cells, evident at the molecular, 
morphological and functional levels, thus the lack of Fkn in isolated microglial cultures is a 
possible reason for the lack of ‘surveying’-like microglia observed in these systems. This 
role could perfectly be carried out by membrane bound or even the constitutively cleaved 
Fkn in vivo, keeping the cells in an alerted but relatively latent state. However, microglial 
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cells stimulated with Fkn exhibit a state which could also be considered as activated, since 
they display a reorganized cytoskeleton coupled with increased phagocytic and mobility 
behaviour. But, as previously mentioned, this is not an ‘activated’ state in the classically 
attributed meaning. In the presence of Fkn, cells seem to exhibit an ‘alternative’ activation 
behaviour. Stimulation of phagocytosis and migration while keeping a low inflammatory 
profile is a characteristic of alternatively (M2) activated macrophages, which allow for 
normal tissue maintenance to be performed without setting off or worsening an 
inflammatory response (Cameron & Landreth 2010). Apparently, exposure to Fkn induces 
such a state in microglia. Curiously, this phenotype switch in microglia has very recently 
been proposed to ameliorate the disease progression in a model of Alzheimer’s disease, as 
well as to have direct influence in the capacity for neurogenesis displayed in healthy and 
diseased CNS (Varnum & Ikezu 2012). Fkn can thus assume a major role as a valuable tool 
in the study and treatment of diseases of the CNS. 
 
Figure 4.1. Different activation states of microglia. Microglia exist in different phenotypic states with 
differing physiological characterizations, ranging from surveying to classical to various alternatively activated 
states. (from (Cameron & Landreth 2010)) 
 
Fkn could thus serve to keep reactive microgliosis at a minimum, a ‘buffer system’ to 
control microglial overreaction in the case of localized, slightly altered brain homeostasis. 
In contrast, major insults or imbalances in the CNS could promote a major shedding of 
Fkn from neuronal cells, thus eliciting another type of response in microglia. This 
differentiated signalling potential can be inferred from the distinct types of Ca2+ transients 
that cleaved and membrane-bound Fkn elicit in these cells (Harrison et al. 1998). But the 
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underlying mechanisms of signal transduction are still in the dark and a great deal of work 
is still required to shed some light on this particular issue. For that purpose, N9 cells could 
be a valuable tool allowing an initial study of different signalling pathways activated by 
soluble and (when used in co-cultures with neurons) membrane attached Fkn. 
That Fkn can be used in vitro to reduce or shift the activation of microglia is definitively 
clear, both from data reviewed or presented here for the first time. Thus, it seems that Fkn 
has a great but as of yet untapped potential as a mechanism to control microglial behaviour 
in vitro, to study the effects of microglia on CNS disease progression in vivo, and quite 
possibly to be used as a means or a target in therapeutic strategies to improve the 
conditions of patients suffering from CNS disorders. 
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Chapter V – Conclusion 
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Considering our work hypothesis, the main aims of this study and the results obtained, we 
conclude that: 
1.- Fkn reduces mRNA levels of the pro-inflammatory cytokines IL-1β and TNF-α in N9 
cells treated with LPS. 
2.- Fkn induces an increase in the phagocytic activity of N9 cells. 
3.- N9 cells morphology is affected by their exposure to Fkn in basal conditions, which 
leads to a more ramified shape of these cells.  
4.- Drastic morphological changes observed in N9 cells after LPS exposition are 
ameliorated by co-treatment with Fkn. 
5.- Fkn increases motility of N9 cells in basal and also LPS stimulated conditions.  
6.- N9 cell culture is a good in vitro model for the study of Fkn effects on microglial cells. 
Summarizing, we conclude that Fkn modulates LPS-mediated activation of N9 microglial 
cells, reducing their production of pro-inflammatory cytokines while maintaining high 
levels of migratory and phagocytic activity.  
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